Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells $67,875.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 125 shares of the firm’s stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $543.00, for a total transaction of $67,875.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $534.28 on Friday. The firm has a market cap of $191.53 billion, a PE ratio of 70.67, a PEG ratio of 4.94 and a beta of 1.61. The firm’s 50 day moving average price is $464.32 and its 200 day moving average price is $498.53. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm posted $1.84 earnings per share. The company’s quarterly revenue was up 22.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently bought and sold shares of ISRG. Chilton Capital Management LLC boosted its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares in the last quarter. Tobam boosted its stake in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares in the last quarter. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the first quarter worth $26,000. Kilter Group LLC acquired a new stake in Intuitive Surgical during the second quarter worth $27,000. Finally, LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the first quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday. Leerink Partners boosted their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Piper Sandler boosted their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Finally, Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.